Article ID Journal Published Year Pages File Type
8226030 International Journal of Radiation Oncology*Biology*Physics 2012 7 Pages PDF
Abstract
Notwithstanding the limitations of our preliminary data Re-RT combined with cetuximab for recurrent and inoperable SCCHN is feasible and the integration of newer targeted agents seems to be less toxic compared to conventional chemotherapy with encouraging response rates at least for a subset of patients.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Reirradiation With Cetuximab in Locoregional Recurrent and Inoperable Squamous Cell Carcinoma of the Head and Neck: Feasibility and First Efficacy Results
Authors
, , , , , , ,